Roseoglobuloside A, a Novel Nonanolide, and Identification of Specialized Metabolites as hPTP1B1 – 400 Inhibitors from Mangrove-Dwelling Aspergillus spp
Planta Medica · 01.04.2025 · 91 (04) · 197-207
DOI: 10.1055/a-2515-9491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.04.2025. Verfasst von Carlos A Fajardo-Hernández und 4 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Química, Departamento de Productos Naturales, Universidad Nacional Autónoma de México, Mexico City, Mexico. Hauptthemen laut MEDLINE: Aspergillus, Protein Tyrosine Phosphatase, Non-Receptor Type 1, Molecular Docking Simulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Sistema Nacional de Investigadores, Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México.
Abstract (Originalsprache)
An approach combining enzymatic inhibition and untargeted metabolomics through molecular networking was employed to search for human recombinant full-length protein tyrosine phosphatase 1B (hPTP1 B1 – 400) inhibitors from a collection of 66 mangrove-associated fungal taxa. This strategy prioritized two Aspergillus strains (IQ-1612, section Circumdati, and IQ-1620, section Nigri) for further studies. Chemical investigation of strain IQ-1612 resulted in the isolation of a new nonanolide derivative, roseoglobuloside A (1), along with two known metabolites (2 and 3), whereas strain IQ-1620 led to the isolation of four known naphtho-γ-pyrones and one known diketopiperazine (4–8). Of all isolates, compounds 2, 3, and 7 showed a marked inhibitory effect on hPTP1B1 – 400 with an IC50 value < 20 µM, while 6 showed moderate inhibition with IC50 of 65 µM. Compounds 1 and 8 were inactive at a concentration of 100 µM, whereas 4 and 5 demonstrated significant inhibition at 20 µM. The structure of 1 was established by comprehensive spectroscopic analysis, and its relative and absolute configuration was assigned based on NOE correlations and by comparison of calculated and experimental ECD curves. Molecular docking indicated that these molecules primarily bind to two different allosteric sites, thereby inducing conformational changes that impact enzymatic activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Instituto de Química, Departamento de Productos Naturales, Universidad Nacional Autónoma de México, Mexico City, Mexico.
- Departamento El Hombre y su Ambiente, Universidad Autónoma Metropolitana, Mexico City, Mexico.
Förderung
- Sistema Nacional de Investigadores
- Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México
Zitieren
APA
Fajardo-Hernández, C. A., Zavala-Sierra, Á. G., Merlin-Lucas, V. I., Morales-Jiménez, J. I., & Rivera-Chávez, J. (2025). Roseoglobuloside A, a Novel Nonanolide, and Identification of Specialized Metabolites as hPTP1B1 – 400 Inhibitors from Mangrove-Dwelling Aspergillus spp. Planta Medica, 91(04), 197-207. https://doi.org/10.1055/a-2515-9491
Vancouver
Fajardo-Hernández CA, Zavala-Sierra ÁG, Merlin-Lucas VI, Morales-Jiménez JI, Rivera-Chávez J. Roseoglobuloside A, a Novel Nonanolide, and Identification of Specialized Metabolites as hPTP1B1 – 400 Inhibitors from Mangrove-Dwelling Aspergillus spp. Planta Medica. 2025;91(04):197-207. doi:10.1055/a-2515-9491
BibTeX
@article{FajardoHernndez2025,
author = {Fajardo-Hernández, Carlos A and Zavala-Sierra, Ángeles G and Merlin-Lucas, Verenice I and Morales-Jiménez, Jesús I and Rivera-Chávez, José},
title = {Roseoglobuloside A, a Novel Nonanolide, and Identification of Specialized Metabolites as hPTP1B1 – 400 Inhibitors from Mangrove-Dwelling Aspergillus spp},
journal = {Planta Medica},
year = {2025},
volume = {91},
number = {04},
pages = {197--207},
doi = {10.1055/a-2515-9491}
}
EUVIMED